Related Experiment Video
Updated: Jun 23, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
HIV-associated pulmonary hypertension: case report
1Aga Khan University Hospital Nairobi, P.O. Box 40374-00100, Nairobi, Kenya.
Highly active antiretroviral therapy has shifted HIV/AIDS lung disease towards non-infectious causes like HIV-associated pulmonary hypertension (HIV-PH). Early screening, diagnosis, and treatment are crucial for managing this condition.
Area of Science:
- Pulmonology
- Infectious Diseases
- Cardiology
Background:
- Highly active antiretroviral therapy (HAART) has altered the disease profile in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS).
- Non-infectious pulmonary complications are increasingly recognized in HIV/AIDS patients.
- HIV-associated pulmonary hypertension (HIV-PH) is a rare but serious condition linked to increased morbidity and mortality.
Observation:
- A case study of a 30-year-old female with HIV disease and severe pulmonary hypertension is presented.
- The patient's presentation highlights the clinical challenges in managing HIV-PH.
Findings:
- While evidence for HIV-PH management is limited, strategies extrapolated from idiopathic pulmonary hypertension are employed.
- The case illustrates the potential severity and impact of HIV-PH.
Implications:
- There is a need for increased awareness and proactive screening for HIV-PH in the HIV/AIDS population.
- Further research into the specific management of HIV-PH is warranted.
- Timely diagnosis and treatment can potentially improve outcomes for patients with HIV-PH.
More Related Videos
08:08Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...